
Chloramphenicol Resistance: Genes and Rapid Detection
Bacteria such as Campylobacter jejuni, Salmonella enterica and Escherichia coli escape chloramphenicol through mutations or acquired resistance genes.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Bacteria such as Campylobacter jejuni, Salmonella enterica and Escherichia coli escape chloramphenicol through mutations or acquired resistance genes.

Clefting of the palate alongside a tongue tied by a short frenulum is the subject, with research on TBX22, DNA damage response and Robin sequence mortality.

Reduced laminin-α2 leaves muscle cells fragile in merosin-deficient CMD, with weakness and contractures; LAMA2 testing also allows prenatal diagnosis.

In people with HIV, the virus, antiretroviral therapy and standard risk factors all shape CAD risk, while imaging and genetic testing guide diagnosis and care.

The rs10757278 variant on chromosome 9p21, loci shared with psoriasis and RETN and IL1RL1 variants are among the genetic findings tied to CAD on this page.

A TaqI variant in the VDR gene, six SNPs from a Japanese population and TGFβ polymorphisms are the susceptibility findings covered, plus how risk is quantified.

Variants in SMAD6, TWIST1 and EFNB1 have been reported in nonsyndromic cases, and one study found no outcome difference between two treatment approaches.

Mainly affecting males, DFNX5 is tied to SMPX, TIMM8A and PRPS1 mutations on the X chromosome; hearing tests and family history guide further genetic testing.